CORCEPT THERAPEUTICS INC
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
CORT$73.35-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income | $99,652 | $141,209 | $106,140 |
| Other comprehensive income (loss): | |||
| Unrealized gain (loss) on available-for-sale investments, net of tax effect of $(308), $118, and $(353), respectively | 1,039 | (598) | 1,120 |
| Foreign currency translation gain (loss) | 1,442 | (228) | 358 |
| Total comprehensive income | 102,133 | 140,383 | 107,618 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.